why choose us

First received: October 03, 2022

Clinical Trial: Anti-Platelets in Chronic Obstructive Pulmonary Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: COPD

Study Type: INTERVENTIONAL


Official Title: Dual Anti-platelet Therapy in Chronic Obstructive Pulmonary Disease Study

Brief Summary: This is a 6 week crossover study in former smokers with and without COPD to evaluate whether 2 weeks of dual antiplatelet therapy (aspirin 81mg and clopidogrel 75mg) improves pulmonary perfusion (i.e.blood flow in the lungs measured on a contrast CT scan) compared to placebo.

Read more